- Home
- OUT vs CPRX Comparison
OUT vs CPRX Comparison
Compare OUT & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUT
- CPRX
- Stock Information
- Founded
- OUT 2013
- CPRX 2002
- Country
- OUT United States
- CPRX United States
- Employees
- OUT N/A
- CPRX N/A
- Industry
- OUT Real Estate Investment Trusts
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- OUT Real Estate
- CPRX Health Care
- Exchange
- OUT Nasdaq
- CPRX Nasdaq
- Market Cap
- OUT 3.2B
- CPRX 2.6B
- IPO Year
- OUT N/A
- CPRX 2006
- Fundamental
- Price
- OUT $17.88
- CPRX $20.77
- Analyst Decision
- OUT Buy
- CPRX Strong Buy
- Analyst Count
- OUT 7
- CPRX 5
- Target Price
- OUT $19.44
- CPRX $33.20
- AVG Volume (30 Days)
- OUT 1.4M
- CPRX 1.7M
- Earning Date
- OUT 11-11-2025
- CPRX 11-05-2025
- Dividend Yield
- OUT 6.61%
- CPRX N/A
- EPS Growth
- OUT N/A
- CPRX 183.96
- EPS
- OUT 0.60
- CPRX 1.65
- Revenue
- OUT $1,796,000,000.00
- CPRX $558,499,000.00
- Revenue This Year
- OUT N/A
- CPRX $16.51
- Revenue Next Year
- OUT $2.79
- CPRX $9.58
- P/E Ratio
- OUT $30.24
- CPRX $12.64
- Revenue Growth
- OUT N/A
- CPRX 28.55
- 52 Week Low
- OUT $12.95
- CPRX $19.05
- 52 Week High
- OUT $19.98
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- OUT 40.89
- CPRX 57.72
- Support Level
- OUT $17.84
- CPRX $19.05
- Resistance Level
- OUT $18.59
- CPRX $21.07
- Average True Range (ATR)
- OUT 0.42
- CPRX 0.58
- MACD
- OUT -0.09
- CPRX 0.16
- Stochastic Oscillator
- OUT 2.10
- CPRX 58.92
About OUT OUTFRONT Media Inc.
Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The Company generates revenue in the form of rental income by allowing other companies to advertise on its properties and structures under short-term contracts. Outfront Media segments its operations into the United States and International units. Although it also owns assets in Canada and Latin America, the company derives the vast majority of its revenue from billboard advertising agreements in the U.S. Roughly half of the U.S. division's revenue comes from its displays in the New York City and Los Angeles markets. Outfront Media's customers include entities within the retail, television, healthcare, and entertainment industries.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).